Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More

LAT2, Mouse, PE, Clone: NAP-07, Abnova™

Mouse monoclonal antibody raised against partial recombinant LAT2.

Supplier:  Abnova Corporation MAB4522

Catalog No. 89-111-869


Only null left
Add to Cart

Description

Description

This gene is one of the contiguous genes at 7q11.23 commonly deleted in Williams syndrome, a multisystem developmental disorder. This gene consists of at least 14 exons, and its alternative splicing generates 3 transcript variants, all encoding the same protein. [provided by RefSeq

Specifications

Specifications

LAT2
Monoclonal
0.1 mg/mL
Mouse monoclonal antibody raised against partial recombinant LAT2.
In PBS (0.2% BSA, 0.09% sodium azide)
HSPC046/LAB/NTAL/WBSCR15/WBSCR5/WSCR5
Mouse
100 μg
Primary
This antibody reacts with Non-T cell activation linker (NTAL), also known as LAB (linker of activated B cells), a 25-30 KDa transmembrane adaptor protein present in membrane microdomains (rafts) of B lymphocytes, NK cells and myeloid cells.
Store in the dark at 4°C. Do not freeze.
Avoid prolonged exposure to light.
Aliquot to avoid repeated freezing and thawing.
IgG1
Flow Cytometry, Immunocytochemistry, Immunoprecipitation, Western Blot
NAP-07
PE
Flow Cytometry (1:30) The optimal working dilution should be determined by the end user.
LAT2
LAT2
Recombinant protein corresponding to partial human LAT2.
RUO
7462
Human, Mouse
Liquid
Product Suggestions

Product Suggestions

Videos
SDS
Documents

Documents

Product Certifications
Promotions

Promotions

Product Content Correction

Your input is important to us. Please complete this form to provide feedback related to the content on this product.

Product Title

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.

Your feedback has been submitted: Thank you for helping us improve our website.